Sosei Heptares’ U.S.$466 Million Acquisition of Idorsia’s Pharmaceuticals Business in Japan and APAC

Martina Bellini
Tagged:

Orrick advised Sosei Heptares.Sosei Heptares has announced its acquisition for U.S.$466 million (JPY 65 billion) of Idorsia’s pharmaceuticals business in Japan and APAC (ex-China). Sosei Heptares…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now